Abbott Laboratories
Abbott Laboratories (ABT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABT · as of Jun 8, 2026
Key Statistics
Explore Abbott Laboratories Data
abt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 41 · Buy rate: 75.6%
The ABT analyst consensus is Buy, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month price target is $127.46, representing +39.96% upside from the current price of $91.07.
Competitors & Peers
abt competitorsABT
BSX
GILD
ISRG
MDT
MRKStock Performance
Full HistoryAbout Abbott Laboratories
Abbott Laboratories together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Dia…
what is abbott laboratories · abt stock overview · abbott laboratories company profile · who is abbott laboratories ceo · abt NYSE · abbott laboratories headquarters · abbott laboratories business segments
About Stock Overview & Key Data
Abbott Laboratories (ABT) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Mar 17, 1980. As of the latest trading session, ABT stock price is $91.07, with a market capitalization of $158.6B. The stock has returned -31.73% over the past 12 months and -27.31% year-to-date.
According to 41 Wall Street analysts, the consensus rating for Abbott Laboratories stock is Buy, with an average 12-month price target of $127.46. In fiscal year 2025, Abbott Laboratories reported revenue of $44.3B and net income of $6.5B. For detailed data — including Abbott Laboratories revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Abbott Laboratories (ABT) stock price is $91.07. The stock is traded on NYSE under the ticker symbol ABT. The 52-week range is $81.97 – $139.06.